Cargando…
Heterogeneity of Glucocorticoid Resistance in Patients with Bronchial Asthma
Bronchial asthma is assumed to be the result of excessive inflammation driven by an aberrant T-helper-2 (Th2) response. Recently, it has begun to be recognized that asthma is a heterogeneous disorder. Glucocorticoids (GCs) are effective treatment for bronchial asthma; however, the inflammation in br...
Autor principal: | Matsumura, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Master Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615268/ https://www.ncbi.nlm.nih.gov/pubmed/23675190 |
Ejemplares similares
-
Inadequate therapeutic responses to glucocorticoid treatment
in bronchial asthma
por: Matsumura, Yasuhiro
Publicado: (2023) -
Comparison of Glucocorticoid (Budesonide) and Antileukotriene (Montelukast) Effect in Patients with Bronchial Asthma Determined with Body Plethysmography
por: Lajqi, Njomza, et al.
Publicado: (2015) -
On Bronchial Asthma
Publicado: (1890) -
Drug Repurposing to Treat Glucocorticoid Resistance in Asthma
por: Wang, Alberta L., et al.
Publicado: (2021) -
Sleep Disorders in Patients with Bronchial Asthma
por: Cukic, Vesna, et al.
Publicado: (2011)